Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 272

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

The WISDOM Study: breaking the deadlock in the breast cancer screening debate

Open access
Esserman, Laura J., the WISDOM Study and Athena Investigators, Anton-Culver, Hoda, Borowsky, Alexander, Brain, Susie, Cink, Thomas, Crawford, Beth, Eklund, Martin, Esserman, Laura, Fenton, Joshua, Heditsian, Diane, Hiatt, Robert A., Hogarth, Michael, Kaplan, Celia, Koenig, Barbara, LaCroix, Andrea, Larsen, Kathryn M., Lee, Vivian, Matthews, Jeffrey, Madlensky, Lisa, Naeim, Arash, Ojeda-Fournier, Haydee, Parker, Barbara A., Sepucha, Karen, Shieh, Yiwey, Stover Fiscalini, Allison, Thompson, Carlie, Tice, Jeffrey, Van ‘T Veer, Laura, Wenger, Neil, Ziv, Elad · 2017 · npj Breast Cancer

Abstract

There are few medical issues that have generated as much controversy as screening for breast cancer. In science, controversy often stimulates innovation; however, the intensely divisive debate over mammographic screening has had the opposite effect and has stifled progress. The same two questions—whether it is better to screen annually or bi-annually, and whether women are best served by beginning screening at 40 or some later age—have been debated for 20 years, based on data generated three to four decades ago. The controversy has continued largely because our current approach to screening assumes all women have the same risk for the same type of breast cancer. In fact, we now know that cancers vary tremendously in terms of timing of onset, rate of growth, and probability of metastasis. In an era of personalized medicine, we have the opportunity to investigate tailored screening based on a woman’s specific risk for a specific tumor type, generating new data that can inform best practices rather than to continue the rancorous debate. It is time to move from debate to wisdom by asking new questions and generating new knowledge. The WISDOM Study (Women Informed to Screen Depending On Measures of risk) is a pragmatic, adaptive, randomized clinical trial comparing a comprehensive risk-based, or personalized approach to traditional annual breast cancer screening. The multicenter trial will enroll 100,000 women, powered for a primary endpoint of non-inferiority with respect to the number of late stage cancers detected. The trial will determine whether screening based on personalized risk is as safe, less morbid, preferred by women, will facilitate prevention for those most likely to benefit, and adapt as we learn who is at risk for what kind of cancer. Funded by the Patient Centered Outcomes Research Institute, WISDOM is the product of a multi-year stakeholder engagement process that has brought together consumers, advocates, primary care physicians, specialists, policy makers, technology companies and payers to help break the deadlock in this debate and advance towards a new, dynamic approach to breast cancer screening.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41523-017-0035-5

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 272

Metadata

Authors
Esserman, L. J., the WISDOM Study and Athena Investigators, Anton-Culver, H., Borowsky, A., Brain, S., Cink, T., Crawford, B., Eklund, M., Esserman, L., Fenton, J., Heditsian, D., Hiatt, R. A., Hogarth, M., Kaplan, C., Koenig, B., LaCroix, A., Larsen, K. M., Lee, V., Matthews, J., Madlensky, L., Naeim, A., Ojeda-Fournier, H., Parker, B. A., Sepucha, K., Shieh, Y., Stover Fiscalini, A., Thompson, C., Tice, J., Van ‘T Veer, L., Wenger, N., & Ziv, E.
Venue
npj Breast Cancer
Published
2017-09-13
Volume
3
Issue
1
Pages
34-34
ISSN
2374-4677 (ISSN-L)
OpenAlex
W2753454143
Cited by
272
References
50
FWCI
7.22
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The WISDOM Study: breaking the deadlock in the breast cancer screening debate. https://app.cochat.ai/papers/10.1038/s41523-017-0035-5
The paper
Esserman, L. J., the WISDOM Study and Athena Investigators, Anton-Culver, H., Borowsky, A., Brain, S., Cink, T., Crawford, B., Eklund, M., Esserman, L., Fenton, J., Heditsian, D., Hiatt, R. A., Hogarth, M., Kaplan, C., Koenig, B., LaCroix, A., Larsen, K. M., Lee, V., Matthews, J., . . . Ziv, E. (2017). The WISDOM Study: breaking the deadlock in the breast cancer screening debate. npj Breast Cancer. https://doi.org/10.1038/s41523-017-0035-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.